NEW YORK (GenomeWeb) – Exosome Diagnostics said today that it has closed a $30 million Series C financing, led by Tiger Partners and Forbion Capital Partners.
Other participants included Blue Ridge Capital, NGN Capital, Arcus Ventures, b-to-v Partners, and CD Ventures among others.